Burden dynamics of pulmonary arterial hypertension in China and the G20 aggregate: a comparative analysis based on the global burden of disease study 2023
Mortality-related PAH burden declined in China and the G20 aggregate, while absolute case numbers increased, underscoring the need for continued surveillance and long-term health-service planning.